Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 13/20 | 0.53 |
| ▸ | TLR9 | Q9NR96 | 3/20 | 0.46 |
| ▸ | FAAH | O00519 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.37 |
| ▸ | ATM | Q13315 | 3/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | MITF | O75030 | 1/20 | 0.36 |
| ▸ | CCR6 | P51684 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | PDE6D | O43924 | 1/20 | 0.35 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22862131 | 0.97 | MGLL (0.58) | MGLLTLR9FAAHALDH1A1HSP90AA1 | |
| SCHEMBL22862185 | 0.88 | MGLL (0.57) | MGLLTLR9FAAHALDH1A1HSP90AA1 | |
| SCHEMBL22862093 | 0.88 | MGLL (0.57) | MGLLTLR9FAAHALDH1A1HSP90AA1 | |
| SCHEMBL22862149 | 0.86 | MGLL (0.40) | MGLLTLR9FAAHALDH1A1HSP90AA1 | |
| SCHEMBL6832688 | 0.77 | TLR9 (0.76) | MGLLTLR9FAAHALDH1A1HSP90AA1 | |
| SCHEMBL22862045 | 0.75 | MGLL (0.54) | MGLLTLR9FAAHALDH1A1HSP90AA1 | |
| SCHEMBL9719950 | 0.75 | MGLL (0.88) | MGLLTLR9FAAHALDH1A1HSP90AA1 | |
| SCHEMBL28616908 | 0.75 | MGLL (0.73) | MGLLTLR9FAAHALDH1A1HSP90AA1 | |
| SCHEMBL22862071 | 0.73 | TLR9 (0.59) | MGLLTLR9FAAHALDH1A1HSP90AA1 | |
| SCHEMBL14089623 | 0.73 | PDE6D (0.44) | MGLLFAAHALDH1A1ATMHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210003921-A1 | COMPOUND, RESIN, COMPOSITION, AND FILM FORMING MATERIAL FOR LITHOGRAPHY USING THE SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-01-07 | — | — | US | disclosed |
| EP-3760611-A1 | COMPOUND, RESIN, COMPOSITION AND FILM-FORMING MATERIAL FOR LITHOGRAPHY USING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-01-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210003921-A1 | COMPOUND, RESIN, COMPOSITION, AND FILM FORMING MATERIAL FOR LITHOGRAPHY USING THE SAME | COL1A1, MLLT3, F12 | MGLL 1551/4885TLR9 2020/4885FAAH 2256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.